Cargando…
Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
BACKGROUND: Iron is required for cellular metabolism, and rapidly proliferating cancer cells require more of this essential nutrient. Therefore, iron regulation may well represent a new avenue for cancer therapy. We have reported, through in vitro and in vivo research involving pancreatic cancer cel...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374870/ https://www.ncbi.nlm.nih.gov/pubmed/32698792 http://dx.doi.org/10.1186/s12885-020-07167-8 |